Filtered By:
Condition: Pain
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 82 results found since Jan 2013.
Top 100 Most-Cited Papers in Herpes Zoster from 2000 to 2022: A Bibliometric Study
CONCLUSION: In terms of the quantity of T100 articles, researchers, and organizations, the US is the predominant country. The most T100 papers were published in the special journal Clinical Infectious Diseases. The most academic focus remain the remedies for postherpetic neuralgia and vaccine development for individualized groups.PMID:37273270 | PMC:PMC10237222 | DOI:10.2147/JPR.S409616
Source: Herpes - June 5, 2023 Category: Infectious Diseases Authors: Ning Gao Meng Li Weiming Wang Lei Wang Zhen Liu Yufeng Guo Source Type: research
Inactivated COVID-19 vaccine-related herpes zoster and post-herpetic neuralgia: Three case reports
In this report, we describe three cases of HZ, one of them with post-herpetic neuralgia (PHN) after receiving inactivated COVID-19 vaccine. The first two patients developed HZ 8 and 10 days after vaccination, respectively. When pain could not be controlled with paracetamol and non-steroidal anti-inflammatories, the patients received weak opioid codeine. In addition, the first patient received gabapentin, and the second patient was applied erector spinae plane block. The third patient was admitted 4 months after the diagnosis of HZ and considered to have PHN and pain palliation was provided with tramadol. Although the exact...
Source: Herpes - April 13, 2023 Category: Infectious Diseases Authors: Meltem Kanar Source Type: research
Ramsay Hunt Syndrome: An Introduction, Signs and Symptoms, and Treatment
This article discusses the etiology, epidemiology, and pathology of Ramsay Hunt syndrome. Clinically it may be presented as a vesicular rash on the ear or even in the mouth, pain in the ear, and facial paralysis. Some other rare symptoms may also be present, which are also discussed in this article. Skin involvement is also seen in some cases as patterns due to anastomoses between cervical and cranial nerves. This article provides an overview of how the varicella-zoster virus causes facial paralysis and other neurological symptoms. Knowing about this condition and its clinical features is essential to make an early diagnos...
Source: Herpes - February 16, 2023 Category: Infectious Diseases Authors: Yuktam Goswami Sagar S Gaurkar Source Type: research
Herpes zoster after COVID-19 vaccination, aspect of pain medicine: a retrospective, single-center study
CONCLUSIONS: COVID-19 vaccination-related HZ showed clinical features similar to those ofthe other HZ.PMID:36746903 | DOI:10.17085/apm.22207
Source: Herpes - February 6, 2023 Category: Infectious Diseases Authors: Ji Hye Lee Yu Yil Kim Hyun Joo Heo Ji Hun Park Hyung Gu Cho Geonbo Kim Source Type: research
Herpes Zoster Following COVID-19 Vaccine Booster
CONCLUSIONS COVID-19 vaccination remains an important measure to prevent transmission of infection and to reduce the mortality and morbidity caused by it. However, healthcare practitioners should be aware of the possible association between COVID-19 vaccination and herpes zoster. Appropriate explanation and safety advice on the possible adverse events following COVID-19 vaccination, including herpes zoster infection, should be given to patients. This will facilitate early recognition and treatment of this condition.PMID:36650730 | DOI:10.12659/AJCR.938667
Source: Herpes - January 18, 2023 Category: Infectious Diseases Authors: Muhammad Shah Shahrudin Mohamed-Syarif Mohamed-Yassin Nik Munirah Nik Mohd Nasir Source Type: research
Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
Viruses. 2022 Nov 29;14(12):2667. doi: 10.3390/v14122667.ABSTRACTInfection with varicella zoster virus typically occurs in children and it can cause primary varicella infection or "chickenpox", or it can reactivate later in life and cause herpes zoster or "shingles". Herpes zoster mainly occurs in older adults, causing a reduction in activities of daily living, impacting quality of life, and may lead to serious complications, including chronic pain. Two vaccines are marketed to prevent herpes zoster: the live zoster vaccine and the non-live, recombinant zoster vaccine. The pre-licensure clinical trials show the efficacy of...
Source: Herpes - December 23, 2022 Category: Infectious Diseases Authors: Yasmin Marra Fawziah Lalji Source Type: research
Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting
Curr Pain Headache Rep. 2022 Nov 23. doi: 10.1007/s11916-022-01094-y. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: The aim of this review is to characterize headache as a vaccine adverse event (VAE) in clinical trials.RECENT FINDINGS: Of the recent phase III vaccine RCTs (non-COVID-19), 53 studies reported on headache (13 infectious agents). The median rate (interquartile range) of headache was 15.6% (IQR: 9.6-37.6%). Of these, 24.5% of the RCTs reported headache greater in the vaccine group compared to the placebo/control group. In the herpes zoster vaccination trials, headache was more common in all active groups: me...
Source: Herpes - November 23, 2022 Category: Infectious Diseases Authors: Kimberly N Garces Alexandra N Cocores Peter J Goadsby Teshamae S Monteith Source Type: research
Quality of life and risk factors in patients with herpes zoster
Conclusions: More than half of the patients with HZ had moderate to severe pain in the past 24 hours, which had a serious negative impact on the physical and mental health of the patients. Elderly patients, acute patients and patients with complications had lower health utility values and worse health status. We suggest that eligible people be vaccinated with HZ vaccine as soon as possible.PMID:36372770 | DOI:10.3760/cma.j.cn112137-20220627-01416
Source: Herpes - November 13, 2022 Category: Infectious Diseases Authors: Q Zhang Z S Huang Q Q Hu W Qin L L Liang F Cui Y Wang F Pan X L Liu L Tang C Ma Z D Yin F Z Wang Source Type: research
An Unusual Case of Arm Pain in a Young Soccer Player: Herpes Zoster in the Pediatric Athlete
Curr Sports Med Rep. 2022 Nov 1;21(11):386-390. doi: 10.1249/JSR.0000000000001005.ABSTRACTHerpes zoster (HZ), shingles, is caused by the varicella-zoster virus (VZV). HZ develops as a reactivation of latent VZV and is characterized by a painful, vesicular rash typically manifesting in a dermatomal distribution on the arms, trunk or face. HZ occurs in individuals who had primary VZV disease (chickenpox) as a child or in those who have received live, attenuated VZV vaccine. HZ is common in the elderly and the immunocompromised, with age being the single greatest risk factor. The incidence of HZ in children is 74/100,000 pers...
Source: Herpes - November 7, 2022 Category: Infectious Diseases Authors: James MacDonald Joy Mosser-Goldfarb Cristina Tomatis Souverbielle Steven Cuff Source Type: research
